Pierre Gravier
Director of Finance/CFO at PTC THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Pierre Gravier is currently an Independent Director at Cassava Sciences, Inc. and the Chief Financial Officer at PTC Therapeutics, Inc. Previously, he worked as a Managing Director at Perella Weinberg Partners from 2013 to 2023.
He holds a graduate degree from Université de Technologie de Compiègne and ESCP Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PTC THERAPEUTICS, INC.
0.07% | 2024-02-14 | 55,800 ( 0.07% ) | 2 M $ | 2024-03-30 |
CASSAVA SCIENCES, INC.
-.--% | 2024-03-18 | 0 ( -.--% ) | - $ | 2024-03-30 |
Pierre Gravier active positions
| Companies | Position | Start |
|---|---|---|
| PTC THERAPEUTICS, INC. | Director of Finance/CFO | 2023-07-12 |
| CASSAVA SCIENCES, INC. | Director/Board Member | 2023-12-06 |
Former positions of Pierre Gravier
| Companies | Position | End |
|---|---|---|
| PERELLA WEINBERG PARTNERS | Corporate Officer/Principal | 2023-06-30 |
Training of Pierre Gravier
| Université de Technologie de Compiègne | Graduate Degree |
| Escp Business School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CASSAVA SCIENCES, INC. | Health Technology |
| PTC THERAPEUTICS, INC. | Health Technology |
| PERELLA WEINBERG PARTNERS | Finance |
- Stock Market
- Insiders
- Pierre Gravier
